Boston Scientific to Participate in BMO Capital Markets Health Care ... ( NATICK Mass. Aug. 3 /- Boston S...)

Boston Scientific to Participate in BMO Capital Markets Health Care Conference

Date:8/3/2009

NATICK, Mass., Aug. 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets 9(th) Annual Focus on Health Care Conference, August 5.

Ray Elliott, President and Chief Executive Officer, will make a 20-minute presentation on Wednesday, August 5(th), beginning at approximately 8:30 a.m. E.T. Following the presentation, Sam Leno, Executive Vice President and Chief Financial Officer, will join Mr. Elliott in a brief question and answer session.

A live webcast of Mr. Elliott's remarks will be available to all interested parties at Boston Scientific's website at www.bostonscientific.com. Please visit the website for details on how to access the webcast. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by BMO Capital Markets. The replay will be archived and available in the Investor Relations site at www.bostonscientific.com by 10:00 a.m. E.T. on August 5.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

    CONTACT:
    Paul Donovan
    508-650-8541 (office)
    508-667-5165 (mobile)
    Media Relations
    Boston Scientific Corporation

    Larry Neumann
    508-650-8696 (office)
    Investor Relations
    Boston Scientific Corporation

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/15/2012)... May 15 (HealthDay News) -- "Team-based care" should be ... Task Force on Community Preventive Services recommended on Tuesday. ... 77 studies that showed improvements in patients, control of ... of health professionals -- a primary care doctor supported ... health worker -- rather than a primary care doctor ...

(Date:5/15/2012)... DETROIT Patients who undergo radical surgery for ... if they,re treated in accredited teaching hospitals with ... also have medical fellowships, according to a new ... which evaluated postoperative complications in 47,100 radical prostatectomy ... those with fewer complications after the surgery were ...

(Date:5/15/2012)... undergo one of the most common treatments for prostate ... to new research by Henry Ford Hospital. , In ... of the surgeon doing the procedure mattered somewhat less ... data gathered throughout the U.S., will be presented this ... Atlanta. , It is both intuitive "practice makes ...

(Date:5/15/2012)... than men after surgical removal of part or all ... dying in the hospital, although they are more likely ... , But Henry Ford Hospital researchers who documented these ... results of the new study, based on population samples ... at the American Urological Association,s Annual Meeting in Atlanta. ...

(Date:5/15/2012)... a team of Rice University freshmen took a mousetrap ... children in the developing world. , "The goal was ... so we could prevent over-hydration and under-hydration," said Melissa ... in Pediatrics) team and a mechanical engineering major. "It,s ... the world, where conditions can be pretty primitive and ...

Breaking Medicine News(10 mins):Health News:U.S. Task Force Issues Blood Pressure Guidelines 2 Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2 Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2 Health News:Women fare better than men, but need more blood after kidney cancer surgery 2 Health News:Women fare better than men, but need more blood after kidney cancer surgery 3 Health News:This 'mousetrap' may save lives 2

[0] U.S. Task Force Issues Blood Pressure Guidelines [0] Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs [0] Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery [0] Women fare better than men, but need more blood after kidney cancer surgery [0] This 'mousetrap' may save lives

... 8 Allscripts-Misys Healthcare,Solutions, Inc., formerly Allscripts Healthcare ... financial results for the three and six,months ended ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ) , ... six months ended November 30, 2008,include results from ...

... International, Inc.,(Nasdaq: CHDX ) ("CHDX" or "the ... and services in the People,s Republic,of China, today announced ... Conference, to be held in Shanghai on January 12th ... UBS Greater China Conference will be held at the ...

... be used when assessing traditional risk factors, experts say , , ... or "biomarkers" -- of inflammation may provide useful information when ... says. , "If you are very high or very low ... study lead author Dr. Vijay Nambi, a cardiologist at the ...

... Company,s Email Encryption business continues to drive overall performanceDALLAS, ... ZIXI ), the leader in hosted services for email ... its chief executive officer, Rick Spurr."We ended the year ... as we booked the highest orders for the year ...

... A proposal by the State of Indiana to close ... the 125,000-member American Legion Department of Indiana to revamp ... to organize and coordinate its members, nearly unanimous opposition ... $50,000 in direct and in-kind support to the home, ...

... YORK, Jan. 8 United Jewish Communities (UJC) and ... raise $10 million to address humanitarian and social needs ... support and stand in solidarity with Israelis during the ... of the Gaza Strip. The funds will enhance programs ...

Allscripts Reports Fiscal 2009 Second Quarter Results Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference Inflammation Markers May Help Predict Stroke Risk Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 Indiana American Legion to Organize, Launch Opposition to Closing of Children's Home UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel

(Date:5/16/2012)... Reportlinker.com announces that a new market ... Global Human Vaccines ... http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and _ This report ... Vaccines in US$ Million by the following ... Prophylactic Vaccines. The report provides separate comprehensive ...

(Date:5/16/2012)... NuMe Health LLC, a biotechnology company developing ... live in the gastrointestinal (GI) tract to support ... closed a $1.5 million Series A financing. NuMe ... clinical trial of its lead cobiotic product, NM504, ... to support maintenance of healthy blood glucose levels ...

(Date:5/15/2012)... 2012 Nephros, Inc. (OTC Bulletin Board: ... developing and marketing filtration products for therapeutic applications, ... results for the three months ended March 31, ... , Received FDA 510(k) clearance to market hemodiafiltration ... and supply agreement with Medica S.p.A. , ...

Breaking Medicine Technology:Global Human Vaccines Industry 2 Global Human Vaccines Industry 3 Global Human Vaccines Industry 4 Global Human Vaccines Industry 5 Global Human Vaccines Industry 6 Global Human Vaccines Industry 7 Global Human Vaccines Industry 8 Global Human Vaccines Industry 9 Global Human Vaccines Industry 10 Global Human Vaccines Industry 11 Global Human Vaccines Industry 12 Global Human Vaccines Industry 13 Global Human Vaccines Industry 14 Global Human Vaccines Industry 15 Global Human Vaccines Industry 16 Global Human Vaccines Industry 17 Global Human Vaccines Industry 18 Global Human Vaccines Industry 19 Global Human Vaccines Industry 20 Global Human Vaccines Industry 21 Global Human Vaccines Industry 22 NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels 2 NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels 3 Nephros Reports First Quarter 2012 Financial Results 2 Nephros Reports First Quarter 2012 Financial Results 3 Nephros Reports First Quarter 2012 Financial Results 4 Nephros Reports First Quarter 2012 Financial Results 5 Nephros Reports First Quarter 2012 Financial Results 6 Nephros Reports First Quarter 2012 Financial Results 7 Nephros Reports First Quarter 2012 Financial Results 8 Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 1 Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 2 Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 3 Stem cells shape up to their surroundings 15787 1 Stem cells shape up to their surroundings 15787 2 Stem cells shape up to their surroundings 15787 3 Redpoint Advances Salt Enhancer Discovery Program 17542 1 Redpoint Advances Salt Enhancer Discovery Program 17542 2 Redpoint Advances Salt Enhancer Discovery Program 17542 3 Redpoint Advances Salt Enhancer Discovery Program 17542 4

[0] Global Human Vaccines Industry [0] NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels [0] Nephros Reports First Quarter 2012 Financial Results

... Presented at International Conference on Malignant ... Shows Dose Dependent Single Agent Activity, BETHESDA, ... biopharmaceutical company developing novel, proprietary antibodies,for the treatment ... update of an ongoing phase 1 clinical trial ...

... Discuss Clinical, Financial ... DUBLIN, Ohio, June 4 In a move that ... of,hospital-acquired infections (HAIs), Cardinal Health announced today that,it will ... will focus on the leadership and operational issues that ...

Other Medicine Technology:Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 2 Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 3 Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 4 Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 5 Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 2 Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 3 Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 4

Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections

... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...

... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...

... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ... size and angle required for large and ...

... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...

Medicine Products:

Punch, Rotary 90 Right Tip, 3.4 mm Straight Shaft Punch, Medium 45 Right Angled Tip, 3.4 mm Straight Shaft Punch, Standard 45 Right Angled Tip, 3.4 mm 15 Right Curved Shaft Punch, Slender 45 Right Angled Tip, 3.4 mm Straight Shaft

Boston Scientific to Participate in BMO Capital Markets Health Care ...( NATICK Mass. Aug. 3 /- Boston S...),Health